At CureVac SE, I lead process development activities from early R&D through late-stage clinical manufacturing. I define experimental strategies and contribute to CMC documentation, including CTD Module 3 development sections and specifications.
As a Scientist I at CureVac SE, I optimized mRNA-LNP manufacturing processes and designed experiments from feasibility studies through DoE campaigns. I also coordinated technology transfer to internal GMP facilities and external CDMOs, supporting troubleshooting, risk assessments, and control strategies.
At IOCB, Bielefeld University, I developed continuous-flow biocatalytic reactions and translated enzymatic transformations from batch to flow with a Python-empowered optimization loop. During my Ph.D. at Cardiff University, I applied flow chemistry and Design of Experiments to reaction monitoring and optimization.
I’m a qualified CMC Specialist with a Ph.D. in Organic Chemistry and a degree in Chemistry and Technology of Drugs. My work includes providing scientific and technical guidance on process development, material qualification, and manufacturing requirements.
